Results 191 to 200 of about 322,248 (364)

Recurrent Respiratory Papillomatosis Foundation Position Statement on the Management of Adults With RRP

The Laryngoscope, EarlyView.
ABSTRACT Objective With regulatory approval of HPV‐specific immunotherapy for recurrent respiratory papillomatosis (RRP) and growing experience with systemic bevacizumab, a management algorithm incorporating these medical treatments is warranted. Data Sources and Methods RRP Foundation (RRPF) Key Opinion Leaders offer a proposed management algorithm ...
Simon R. Best, Aaron D. Friedman, Clark A. Rosen, Robert T. Sataloff, Laura A. Matrka, H. Steven Sims, David E. Rosow, Nabil F. Saba, David G. Lott, Adam M. Klein, Ted Mau, Milan R. Amin, Kathryn A. Wikenheiser‐Brokamp, Scott M. Norberg, Kim McClellan, Geoffrey D. Young, Clint T. Allen, on behalf of the Recurrent Respiratory Papillomatosis Foundation   +17 more
wiley   +1 more source

Informative High-Risk HPV Genotyping in Cervical Cancer Screening: Integrated Analysis of Cytology and p16/Ki67 Dual Staining. [PDF]

Cancers (Basel)
Trzeszcz M, Mazurec K, Mazurec M, Kobierzycki C, Halon A, Jach R.   +5 more
europepmc   +1 more source

Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices.

MMWR. Morbidity and mortality weekly report, 2016
E. Meites, A. Kempe, L. Markowitz
semanticscholar   +1 more source

The Patient Perspective of Living With Recurrent Respiratory Papillomatosis

The Laryngoscope, EarlyView.
This study was conducted to better understand the perspectives and real‐world impact of the disease burden on patients diagnosed with recurrent respiratory papillomatosis (RRP) and caregivers who experience the disease daily. RRP results in clinical, financial, and psychosocial burdens. Increased public awareness of human papillomavirus (HPV) infection
Sara I. Pai, Walter Ochieng, Nancy Hedlund, Amanda Martino, Neha Chohan, Mir Pawlak, Edith Morais, Kim McClellan   +7 more
wiley   +1 more source

Protective Human Papillomavirus Type 16/18 Vaccine-Induced Neutralizing Antibody Levels Remain Elusive. [PDF]

Open Forum Infect Dis
Lehtinen M, Eriksson T, Petäjä T, Harjula K, Heikkilä K, Hokkanen M, Butt J, Michels B, Sehr P, Müller M, Pimenoff V, Waterboer T.   +11 more
europepmc   +1 more source

Papillomavirus [PDF]

, 2019
openaire   +1 more source

A Randomized Single‐Center Proof of Principle Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal

Lasers in Surgery and Medicine, EarlyView.
ABSTRACT Background Laser hair removal (LHR) is a commonly performed aesthetic procedure known to generate a hazardous laser plume composed of toxic chemicals, ultrafine particles, and potentially infectious biological materials. Current mitigation strategies, such as smoke evacuation systems, are costly and often used inconsistently, highlighting the ...
Barry E. DiBernardo, Gabriella A. DiBernardo, Jason N. Pozner   +2 more
wiley   +1 more source

Need for gender-neutral human papillomavirus vaccination: Lessons from a retrospective epidemiologic investigation of human papillomavirus infections among outpatients presenting to a tertiary dermatology hospital in Central China from 2017 to 2024. [PDF]

IJID Reg
Zhou X, Mo H, Zhou Z, Xu Y, Li C, Tao X.
europepmc   +1 more source

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

New England Journal of Medicine, 2007
S. Garland, M. Hernández-Ávila, C. Wheeler, Gonzalo Pérez, D. Harper, S. Leodolter, G. W. Tang, D. Ferris, M. Steben, J. Bryan, F. Taddeo, Radha A. Railkar, M. Esser, H. Sings, M. Nelson, J. Boslego, Carlos A. Sattler, E. Barr, L. Koutsky   +18 more
semanticscholar   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

Mass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik, Petr Lapcik, Pavla Bouchalova, Pavel Bouchal   +3 more
wiley   +1 more source